Overview

Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
0
Participant gender:
Male
Summary
The study is a randomized controlled trial studying the acute effect of intense aerobic exercise upon NK (Natural Killer) cell activation and appetite-regulation in human participants with or without concommitant IL-6R receptor blockade (Tocilizumab)
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Rigshospitalet, Denmark
Criteria
Inclusion Criteria:

- recreationally active

- moderately trained

- healthy young males aged 18-40 years

- BMI from 18-30 kg·m2

Exclusion Criteria:

- Cardiovascular disease

- Rheumatologic disease

- Metabolic disease,

- Elite sports or high aerobically training status (VO2max>60ml O2/min/kg),

- Frequent/chronic use of medications affecting physical performance or inflammation
(NSAIDS, DMARDS)